LymphoONE T-Cell Expansion Xeno-Free Medium

Description

LymphoONE T-Cell Expansion Xeno-Free Medium is specifically formulated for expansion and transduction of human T lymphocytes. The medium has been optimized to enable efficient T-cell proliferation with or without the addition of human serum or plasma. LymphoONE medium contains no proteins other than pharmaceutical-grade human serum albumin and recombinant human insulin, and provides superior performance relative to other commonly used serum-free media. T-cell activation using LymphoONE T-Cell Expansion Xeno-Free Medium in combination with anti-CD3 antibody, IL-2, and RetroNectin reagent results in enhanced T-cell expansion and yields higher proportions of naive T cells relative to approaches employing IL-2 in combination with anti-CD3 and anti-CD28 antibodies.LymphoONE medium also contains L-glutamine and streptomycin, and is confirmed to have low endotoxin levels <0.3 EU/ml . Catalog # WK552 consists of 10 1-liter bottles of the medium. Our products are to be used forResearch Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval. Back T-cell expansion comparison using various serum-free culture media.Peripheral blood mononuclear cells PBMCs were isolated from blood obtained from two healthy donors and cultured for four days under stimulation by anti-CD3 monoclonal antibody and IL-2 in CultiLife 215 Culture Bags using LymphoONE T-Cell Expansion Xeno-Free Medium, GT-T551 Takara Bio , X-VIVO 15 Lonza , or AIM V Thermo Fisher Scientific . The cells were then cultured at appropriate dilutions for an additional 10 days in each of the respective media supplemented with IL-2. By Day 14, cells cultured in LymphoONE medium exhibited higher fold expansion than cells cultured in either of the other three media. Back T-cell expansion via stimulation by anti-CD3 antibody, IL-2, and RetroNectin in the presence or absence of human serum.Peripheral blood mononuclear cells PBMCs were cultured for four days under stimulation by anti-CD3 monoclonal antibody, IL-2, and RetroNectin reagent in CultiLife 215 Culture Bags with or without addition of human serum using LymphoONE T-Cell Expansion Xeno-Free Medium, X-VIVO 15 Lonza , or AIM V Thermo Fisher Scientific . The cells were then cultured at appropriate dilutions with or without serum for an additional six days in each of the respective media supplemented with IL-2. Human serum was added at a concentration of 1 % from Day 0 to Day 7, and then at a concentration of 0.5 % from Day 7 to Day 10.Top panel.By Day 10, cells cultured in LymphoONE medium exhibited higher fold expansion than cells cultured in either of the other two media, regardless of whether serum was added.Bottom panel.Expansion in LymphoONE medium also resulted in higher proportions of cells expressing markers associated with naive T-cell phenotype CD45RA+/CCR7+ . Back T-cell expansion protocol using RetroNectin reagent, LymphoOne xeno-free medium, CultiLife bags, and anti-CD3 mAb. Back